COVID-19 updates, including vaccine information, for our patients and visitors Learn More

Menu
Search

Two UC San Diego Physician-Scientists Named to Association of American Physicians

 

May 07, 2007  |  

The Association of American Physicians (AAP) has elected two physician-scientists from the University of California, San Diego School of Medicine faculty as new members: Patricia Finn, MD, PhD, Chief of Pulmonary and Critical Care Medicine and Anthony Wynshaw-Boris, MD, PhD, Director, Center for Human Genetics and Genomics Chief, Division of Genetics, Department of Pediatrics.

The Association of American Physicians is a nonprofit, professional organization founded for "the advancement of scientific and practical medicine."  Today, the Association is composed of about 1,000 active members and approximately 550 emeritus and honorary members from the United States, Canada and other countries.

Each year, the Council of the Association elects 60 new members.  This year, 67 inductees were announced at the AAP national meeting in April.

Finn was recognized for her pioneering research regarding the mechanisms behind the development of asthma and other inflammatory lung diseases.  Finn is especially interested in understanding how asthma develops early in life and discovering new ways to prevent and treat asthma and other related diseases.

Wynshaw-Boris’ focus is on the genetic manipulation of mice to generate a number of mouse models which replicate human diseases.  He has used the insights obtained from these animals to define novel pathways for disease pathogenesis and therapeutics. 

# # #

Media Contact:  Kim Edwards,  619-543-6163,

kedwards@ucsd.edu




Media Contact

Share This Article


Related News

4/15/2021
Moores Cancer Center at UC San Diego Health is among the few clinical trial sites in the U.S. for the Pancreatic Cancer Action Network’s (PanCAN) newly created Precision Promise, the first large-scale ...
4/14/2021
The UC San Diego Autism Center for Excellence has received a $1.5 million gift from Kristin Farmer, founder and chief executive officer of ACES, a company that provides services to children with autis ...
4/2/2021
UC San Diego researchers found that the chemical inhibitor K777 reduces the coronavirus’ ability to infect cell lines by blocking human enzyme cathepsin L; clinical trials are underway.
4/1/2021
UC San Diego students will participate in nationwide clinical trial to assess if COVID-19 vaccination prevents infection and reduces risk of transmission.



Follow Us